eagle-i Harvard UniversityHarvard University
See it in Search

Cancer Pharmacology Core (DF/HCC)

Director: Supko, Jeffrey, Ph.D.

Location: Massachusetts General Hospital, 32 Fruit Street, Jackson Building, 10th Floor, Boston, MA 02125

Summary:

The Cancer Pharmacology Core provides DF/HCC investigators with the necessary expertise and resources to design and undertake pharmacokinetic studies in the context of phase I and phase II clinical trials, and preclinical investigations. The core has the ability to implement and validate previously developed analytical methods to quantify drugs and their metabolites in biological fluids as well as the capability to modify or develop entirely new assays when warranted. The core also offers comprehensive analysis of pharmacokinetic data as an additional service, including the estimation of pharmacokinetic parameters and identifying their relationship to pathophysiological variables and pharmacodynamic effects.

Affiliations:

People:

Resources:

Services


Web Links:

Last updated: 2012-08-06T16:08:15.841-05:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016